Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 25,756 shares at $28.36 ($730K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Scheduled sale ($730k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.36 | 12,878 | $365K | 50.0% |
| 2 | $28.36 | 12,878 | $365K | 50.0% |
| Total | $28.36 avg | 25,756 | $730K | 100% |
| Filing → |
| RGNX | SELL | 2026-05-13 | $169K | — | Filing → |
| RGNX | SELL | 2026-03-12 | $53K | — | Filing → |
| RGNX | SELL | 2024-01-04 | $600K | — | Filing → |